The effect of body weight on the severity and clinical course of ulcerative colitis (Q44211308)

30 November 2017

The effect of body weight on the severity and clinical course of ulcerative colitis (English)

1 reference

30 November 2017

Denia Stabroth-Akil

1

1 reference

30 November 2017

Ludger Leifeld

2

1 reference

30 November 2017

Roland Pfützer

3

1 reference

30 November 2017

Julia Morgenstern

4

1 reference

30 November 2017

Wolfgang Kruis

5

1 reference

30 November 2017

14 November 2014

1 reference

International Journal of Colorectal Disease

30 November 2017

1 reference

30 November 2017

30

1 reference

30 November 2017

237-242

1 reference

30 November 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s00384-014-2051-3

30 November 2017

0 references

cites work

Inflammation and metabolic disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Systematic review: adipose tissue, obesity and gastrointestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Adipokines: inflammation and the pleiotropic role of white adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Body mass index and diverticular disease: a 28-year follow-up study in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Obesity increases the risks of diverticulitis and diverticular bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Leptin and adipocytokines: bridging the gap between immunity and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Transplantation of wild-type white adipose tissue normalizes metabolic, immune and inflammatory alterations in leptin-deficient ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Percentiles of body mass index of 18-80-year-old German adults based on data from the Second National Nutrition Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

A brief report of the epidemiology of obesity in the inflammatory bowel disease population of Tayside, Scotland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Juvenile onset inflammatory bowel disease: height and body mass index in adult life

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Nutrition assessment of patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Nutritional follow-up of patients with ulcerative colitis during periods of intestinal inflammatory activity and remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Inflammatory bowel disease: nutritional implications and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Significant differences between Crohn's disease and ulcerative colitis regarding the impact of body mass index and initial disease activity on responsiveness to azathioprine: results from a European multicenter study in 1,176 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00384-014-2051-3

Non-alcoholic fatty liver disease and hepatitis C infection.

21 January 2018

1 reference

12 December 2020

The impact of increased body mass index on the clinical course of Crohn's disease

1 reference

12 December 2020

The metabolic impact of active ulcerative colitis. Energy expenditure and nitrogen balance.

1 reference

12 December 2020

Obesity: preventing and managing the global epidemic. Report of a WHO consultation

1 reference

12 December 2020

Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease

1 reference

12 December 2020

Obesity and the risk of severe acute pancreatitis

1 reference

12 December 2020

Body composition in patients with inflammatory bowel disease: a population-based study

1 reference

12 December 2020

Crohn's disease clinical course and severity in obese patients

1 reference

12 December 2020

Resistin is an inflammatory marker of inflammatory bowel disease in humans

1 reference

12 December 2020

Metabolic features of inflammatory bowel disease in a remission phase of the disease activity

1 reference

12 December 2020

10.1007/S00384-014-2051-3

Identifiers

DOI

1 reference

30 November 2017

1 reference